Yasuhide Hayashi

Isesaki, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications

Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

Journal: British journal of haematology
Published: March 25, 2026

A Three-Dimensional Culture-Drug Sensitivity Test Predicts MDM2 Inhibitor-Sensitivity in SMARCB1/INI1-Deficient Tumors.

A Three-Dimensional Culture-Drug Sensitivity Test Predicts MDM2 Inhibitor-Sensitivity in SMARCB1/INI1-Deficient Tumors.

Journal: Cancer science
Published: January 30, 2026

Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

Journal: Leukemia
Published: November 01, 2025

Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesis.

Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesis.

Journal: Leukemia
Published: October 23, 2025

Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).

Journal: British journal of haematology
Published: September 12, 2025

Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia.

Age-specific mutation profiles and their prognostic implications in pediatric KMT2A-rearranged acute myeloid leukemia.

Journal: Haematologica
Published: June 15, 2025

KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.

KRAS G12 mutations as adverse prognostic factors in KMT2A-rearranged acute myeloid leukemia.

Journal: Leukemia
Published: March 19, 2024

High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

Journal: Pediatric blood & cancer
Published: January 15, 2024

NPM1-fusion proteins promote myeloid leukemogenesis through XPO1-dependent HOX activation.

NPM1-fusion proteins promote myeloid leukemogenesis through XPO1-dependent HOX activation.

Journal: Leukemia
Published: October 10, 2023

Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.

Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.

Journal: Blood
Published: September 12, 2023

Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial.

Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial.

Journal: Blood advances
Published: September 08, 2023

Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia.

Development and validation of a promising 5-gene prognostic model for pediatric acute myeloid leukemia.

Journal: Molecular biomedicine
Published: August 26, 2023
Showing 1-12 of 104

Last Updated: 09/26/2026